I think they expected Nigeria to come online first but with the election turmoil there it's slowed that process down. It might be something completely different but that's what I've been thinking.
As I said, I don't think it means profitability is pushed back 6 months. Of course, it's confusing, so we're not sure. We definitely need Nigeria for the original timeline to not be pushed back.
I would not call it "cash problems", even if we do only have Kenya (which shouldn't be the case). As long as these purchase orders start flowing in as they are contracted to do so, the debt will be eliminated in a relatively short amount of time. Compared to the debt that other biotechs can generate in their startup phase, I think we're doing well here. This will be a very significant revenue channel, and under $10m debt is pretty good IMO.